MSIS Executive committee

TU Vienna, Austria

Martina has been working in the field of Instrumental Bioanalytical Chemistry for more than 20 years with a special focus on mass spectrometry, separation sciences, biomolecule identification and detailed characterization. She is a well-known expert in proteomics, glycomics focussing on method development, future directing applications of mass spectrometry and instrument improvements. Since 2009 she has established MALDI mass spectrometric imaging in Austria and is an internationally recognized expert in the field building her capacities through European based networks and national collaborations in the fields of Life Sciences and Material Sciences. Current research is focused on 1) applying MALDI and DESI as soft ionization techniques for surface analysis in the field of MSI; 2) developing sample preparation strategies to gather omics information from sample surfaces and combine this strategy with classical LC-MS approaches; and 3) combining the emerging field of MS imaging with methodologies traditionally used in other fields, i.e. MRI, CT, PET, IR, Raman (medicine) or XRF, and AFM (material sciences), building a strong basis for new developments in multimodal imaging.

Malcolm is Head of Research for the Biomolecular Sciences Research Centre, Dept. of Biosciences and Chemistry, Sheffield Hallam University in the United Kingdom. He is the leader of the Mass Spectrometry and MALDI Special Interest Group of the British Mass Spectrometry Society, Vice President of the Mass Spectrometry Imaging Society and Associate Editor of the Journals Proteomics and Nature Scientific Reports. Malcolm is the author of 136 peer reviewed papers to date including 75 on mass spectrometry imaging. He has supervised 34 PhD students to completion. Malcolm’s current major research interests are in the application of mass spectrometry imaging techniques to the understanding of response mechanisms to xenobiotic exposure in tissues and 3D tissue models and the development of quantitative imaging techniques.

University of Geneva, Switzerland

Gérard is full Professor for Analytical Sciences and Mass Spectrometry in the Department of Analytical and Inorganic Chemistry of the University of Geneva. His research interests focus around the development and application of novel mass spectrometry approaches with and without chromatography in the field of life sciences. His scientific interests include: hyphenation of separation sciences with MS, automation, bioanalysis, metabolism, metabolomics, analytical proteomics, ionization techniques, MS/MS fragmentation, ion mobility mass spectrometry and mass spectrometry imaging. He acts as an editor for Analytical Bioanalytical Chemistry and he is member of the scientific committee of the HPLC Conference Series.

Uppsala University, Sweden

Ingela is a full Professor of Analytical Chemistry at the Department of Chemistry-BMC, Uppsala University, Sweden. After a PhD in 2011 from the University of Gothenburg, Sweden, she did a post doc at Pacific Northwest National Laboratory, USA. Following, she started her independent career in 2014 at Uppsala University. Her research is focused on developing and applying new mass spectrometry tools for the analysis metabolites and lipids, including low abundant and isomeric species, in tissue and cells. The overall aim to use novel analytical tools to realize the chemistry behind biological function.

Imperial College London, England

Stefania is a postdoctoral researcher at Imperial College London Analytical Chemist London, England.

Ruminant Biotech, New Zealand

TS SCI.com

Tiffany was raised as a MS Imaging child as her academic career (2008 – 2021) focused on method development and application of the technique in various areas (forensics, plant biology, clinical research, pharmaceutical). In April 2021, she joined Boehringer Ingelheim, in Biberach (Germany) as Senior Scientist in the Drug Metabolism Sciences group. In 2023, Tiffany moved to New Zealand and joined Ruminant Biotech as Senior Researcher and Market Access manager. She is a freelance content editor and web designer since November 2023.

AstraZeneca, UK

Gregory is a Director at AstraZeneca (AZ) from the Imaging & Data Analytics team in Clinical & Pharmaceutical Safety Sciences (CPSS). He holds a PhD in physics and chemistry from the Paul Verlaine University of Metz (France) in 2010. As R&D manager in the MS imaging department of ImaBiotech from 2010 to 2016, he developed a new methodology for quantification by MSI (patented and published extensively) and coordinated international research program for the company. Since 2016, he’s supporting AstraZeneca portfolio using a range of advanced imaging technology including MSI, Imaging Mass Cytometry (IMC) and digital pathology. He has extensive experience in supporting projects for safety and efficacy studies and is therapy area lead for Respiratory & Immunology. He’s the author of over 40 peer reviewed papers in the field these last 11 years and as chairman of the MSI study group for the European Society of Molecular Imaging (ESMI) he strives to promote the multimodality MSI to wider imaging community.

GSK, UK

After graduating from the University of Hull in 1984 Peter did a PhD at the University of Reading in collaboration with ICI Plant Protection Division (now Syngenta) at Jealott’s Hill, Berkshire. He joined Glaxo (now GlaxoSmithKline) in February 1988 as a Natural Product Extraction Chemist before moving into the mass spectrometry group in 1993. His many roles included the development of methodologies for analysing compounds from single resin beads as part of the combinatorial chemistry era. This work also included the use of Inductively Coupled Plasma mass spectrometry (ICP-MS) which led us into MALDI MS imaging about 12 years ago. Peter pioneered the introduction of MALDI MS Imaging into GSK and was an active member of the recent European Union Cooperation in Science and Technology (COST) Action for MALDI MS Imaging representing the UK. In this capacity, Peter was instrumental in organising and co-running several workshops for the advancement of techniques for On-Tissue Digestion prior to MALDI Imaging analysis. Peter was part of the original Team that helped co-found the Mass Spectrometry Imaging Society (MSIS) and is currently serving as the Industrial Link on the board of the MSIS. Peter’s use of MALDI MS Imaging has recently morphed into Ultra High Throughput Screening by MALDI and through a collaboration between GSK, Bruker and Analytik Jena/Cybio has led to the development of a fully Automated system that has the potential to spot and analyse a full diversity 2 million compound assay in ~8 days.

Shimadzu, Germany

Ann-Christin studied Chemistry at the University of Münster, Germany and finished her Master of Science Chemistry in 2013. Her thesis focused on elemental bioimaging of metal-tagged drug delivery systems by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). During her PhD, she performed complementary imaging using MALDI-MS for molecular, and LA-ICP-MS for elemental imaging. Analysis has been performed on different samples such as tumor spheroids, rat brain sections and human brain tumors. Furthermore, multimodal analysis with magnetic resonance imaging (MRI) were carried out. She finished 2016 her PhD at the University of Münster, Germany in the research group of Prof. Uwe Karst and received for her thesis the Wolfgang Paul Study Award from the German Society of Mass Spectrometry (DGMS) as well as the DAAS Award from the work group Analytical Spectroscopy of the German Society of Chemistry. Dr. Niehoff is currently working at Shimadzu Europa GmbH, Duisburg, Germany, for the European Innovation Center – Imaging. The focus of her work is to establish collaborations with scientific researchers for the development of new applications and technologies in the field of imaging.

University of Bayreuth, Germany

Andreas is Full Professor and Chair Bioanalytical Sciences and Food Analysis, University of Bayreuth.

Münster, Germany

WWU Münster, Institut für Hygene